Diabetes Market Size in the 7MM is expected to grow by 2032 | DelveInsight

Diabetes Market Size in the 7MM is expected to grow by 2032 | DelveInsight

DelveInsight’s “Diabetes Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Diabetes, historical and forecasted epidemiology as well as the Diabetes market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Key Takeaways from the Diabetes Market Research Report

  • The increase in Diabetes Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
  • As per DelveInsight analysis, the Diabetes Market is anticipated to witness growth at a considerable CAGR.
  • The leading Diabetes Companies working in the market include Enthera, Nano Precision Medical, Oramed, Dompe Farmaceutici, Carmot Therapeutics, Scohia Pharma, Genexine, REMD Biotherapeutics, and others.
  • Promising Diabetes Pipeline Therapies in the various stages of development include LY2963016, Lantus, OAMs, ORMD-0801, exenatide, Cotadutide, and others.
  • April 2024:- Omada Health Inc.- Randomized Controlled Trial to Evaluate the Efficacy of an Integrated Lifestyle Management Solution With Continuous Glucose Monitoring for Type 2 Diabetes. The goal of this study is to examine the efficacy of an integrated solution, defined as a combination of the Abbott FreeStyle Libre 14-day CGM sensor and the Omada care team’s receipt of real-time, continuous glucose data from the sensor and incorporation of this data into their care delivery within the context of the Omada for Diabetes program for adults with Type 2 Diabetes (T2D).
  • April 2024:- Merck Sharp & Dohme LLC– A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in Pediatric Participants (Ages 10 to 17 Years, Inclusive) With Type 2 Diabetes Mellitus. This study will evaluate the safety and efficacy of ertugliflozin (MK-8835) in pediatric participants with T2DM on metformin with/without insulin. The primary hypothesis of the study is that the addition of ertugliflozin reduces hemoglobin A1C (HbA1C) more than the addition of placebo after 24 weeks of treatment.


Discover which therapies are expected to grab the Diabetes Market Share @ Diabetes Market Outlook


Diabetes Overview 

Diabetes is a chronic medical condition that occurs when the body is unable to properly regulate blood sugar (glucose) levels. Glucose is the primary source of energy for cells in the body, and insulin, a hormone produced by the pancreas, helps regulate the amount of glucose in the bloodstream.


Diabetes Epidemiology Insights

The epidemiology section of Diabetes offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.


Download the report to understand which factors are driving Diabetes Epidemiology trends @ Diabetes Epidemiological Insights


Diabetes Drugs Market

The Diabetes Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Diabetes signaling in Diabetes are likely to uncover new therapeutic targets and further expand treatment options for patients.


Diabetes Treatment Market Landscape

The Diabetes treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Diabetes has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.


To know more about Diabetes treatment guidelines, visit @ Diabetes Treatment Market Landscape


Diabetes Market Outlook

The report’s outlook on the Diabetes market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Diabetes therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Diabetes drug and late-stage pipeline therapy. It assesses their impact based on various factors such as annual therapy costs, inclusion/exclusion criteria, mechanism of action, compliance rates, market demand, patient population growth, covered patient segments, anticipated launch year, competition with other therapies, brand value, and input from key opinion leaders. The analyzed Diabetes market data are presented concisely through relevant tables and graphs to offer a clear overview of the market dynamics.


Diabetes Drugs Uptake

The drug chapter of the Diabetes report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Diabetes.


Major Diabetes Companies

Several Diabetes Companies working in the market include Enthera, Nano Precision Medical, Oramed, Dompe Farmaceutici, Carmot Therapeutics, Scohia Pharma, Genexine, REMD Biotherapeutics, and others.


Learn more about the FDA-approved drugs for Diabetes @ Drugs for Diabetes Treatment


Scope of the Diabetes Market Research Report

  • Coverage- 7MM
  • Diabetes Companies- Enthera, Nano Precision Medical, Oramed, Dompe Farmaceutici, Carmot Therapeutics, Scohia Pharma, Genexine, REMD Biotherapeutics, and others.
  • Diabetes Pipeline Therapies- LY2963016, Lantus, OAMs, ORMD-0801, exenatide, Cotadutide, and others.
  • Diabetes Market Dynamics: Diabetes Market Drivers and Barriers
  • Diabetes Market Access and Reimbursement, Unmet Needs and Future Perspectives


Discover more about Diabetes Drugs in development @ Diabetes Clinical Trials Assessment


Table of Content

1. Key Insights

2. Executive Summary of Diabetes

3. Diabetes Competitive Intelligence Analysis

4. Diabetes Market Overview at a Glance

5. Diabetes Disease Background and Overview

6. Diabetes Patient Journey

7. Diabetes Epidemiology and Patient Population

8. Diabetes Treatment Algorithm, Current Treatment, and Medical Practices

9. Diabetes Unmet Needs

10. Key Endpoints of Diabetes Treatment

11. Diabetes Marketed Products

12. Diabetes Emerging Therapies

13. Diabetes Market Analysis (Size and Share Assessment)

14. Attribute analysis

15. Diabetes Market Outlook (in the 7MM)

16. Access and Reimbursement Overview of Diabetes

17. KOL Views

18. Diabetes Market Drivers

19. Diabetes Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight


About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/